Keyphrases
1-year Outcome
100%
All-cause Mortality
14%
Anticoagulant Therapy
14%
Anticoagulants
100%
Antiplatelet Therapy
14%
Antithrombotic Therapy
14%
Asian Patients
42%
Baseline Characteristics
14%
Clinical Outcomes
14%
Clinical Profile
14%
Clinical Trials
14%
Confidence Interval
14%
Coronary Artery Disease
28%
Diabetes
28%
Etiology
14%
Fibrillation
100%
Global Averaging
14%
Global Prevalence
14%
High Stroke Risk
14%
Hypertension
14%
India
100%
International Normalized Ratio
28%
Major Bleeding
14%
New-onset Atrial Fibrillation
100%
Newly Diagnosed
28%
Non-interventional
14%
Non-valvular Atrial Fibrillation
28%
Oral Anticoagulant Therapy
14%
Ratio Values
14%
Registry Data
14%
Rest of the World
14%
Risk Factors
14%
Risk Profile
100%
Stroke Risk
14%
Systemic Embolism
14%
Treatment Patterns
14%
Unique Identifier
14%
Vitamin K Antagonists
28%
Working Diagnosis
14%
Medicine and Dentistry
All Cause Mortality
16%
Anticoagulant Therapy
33%
Antiplatelet
16%
Antithrombotic
100%
Apoplexy
50%
Atrial Fibrillation
100%
Clinical Trial
16%
Coronary Artery Disease
33%
Diabetes
33%
Fibrillation
100%
Major Bleeding
16%
Prevalence
16%
Vitamin K Antagonist
33%
Biochemistry, Genetics and Molecular Biology
All Cause Mortality
33%
Anticoagulation
33%
Atrial Fibrillation
100%
Clinical Trial
33%
Prevalence
33%
Vitamin K
66%